Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Cash & Equivalents	88.04	79.46	137.59	255	97.36	Upgrade
Cash & Short-Term Investments	88.04	79.46	137.59	255	97.36	Upgrade
Cash Growth	10.79%	-42.24%	-46.05%	161.92%	92.14%	Upgrade
Accounts Receivable	-	7.17	4.97	2.86	2.5	Upgrade
Other Receivables	-	15.98	4.11	13.62	15.02	Upgrade
Receivables	-	23.15	9.08	16.48	17.52	Upgrade
Inventory	-	60.19	51.54	57.75	41.42	Upgrade
Prepaid Expenses	0.08	1.03	0.77	0.86	1.49	Upgrade
Restricted Cash	-	10.02	10.01	1.4	1.39	Upgrade
Total Current Assets	88.12	173.85	208.99	331.49	159.19	Upgrade
Property, Plant & Equipment	-	60.49	55.64	48.77	39.42	Upgrade
Long-Term Deferred Tax Assets	-	25.33	26.21	13.08	8.45	Upgrade
Other Long-Term Assets	10	34.79	59.67	43.67	30.67	Upgrade
Total Assets	98.12	294.47	350.5	437.02	237.73	Upgrade
Accounts Payable	1.69	25.31	10.89	15.28	2.17	Upgrade
Accrued Expenses	0.08	39.72	30.84	34.6	5.81	Upgrade
Current Portion of Leases	-	1.06	0.29	0.32	0.31	Upgrade
Current Income Taxes Payable	-	-	-	0.2	0.66	Upgrade
Current Unearned Revenue	-	212.42	230.91	296.4	131.05	Upgrade
Other Current Liabilities	-	2.13	0.25	1.97	1.79	Upgrade
Total Current Liabilities	1.77	280.64	273.17	348.77	141.78	Upgrade
Long-Term Leases	-	6.79	2.35	1.58	1.9	Upgrade
Other Long-Term Liabilities	-	1.2	1.2	1.2	1.2	Upgrade
Total Liabilities	1.77	288.63	276.73	351.55	144.88	Upgrade
Common Stock	22.66	22.66	22.66	22.66	22.66	Upgrade
Additional Paid-In Capital	22.51	22.51	22.51	22.51	22.51	Upgrade
Treasury Stock	-9.97	-9.97	-9.97	-9.97	-9.97	Upgrade
Comprehensive Income & Other	61.15	-29.37	38.57	50.26	57.64	Upgrade
Shareholders' Equity	96.35	5.84	73.77	85.46	92.85	Upgrade
Total Liabilities & Equity	98.12	294.47	350.5	437.02	237.73	Upgrade
Total Debt	-	7.85	2.64	1.9	2.21	Upgrade
Net Cash (Debt)	88.04	71.62	134.95	253.1	95.15	Upgrade
Net Cash Growth	22.93%	-46.93%	-46.68%	166.01%	-	Upgrade
Net Cash Per Share	7.27	5.91	11.15	20.90	7.86	Upgrade
Filing Date Shares Outstanding	12.11	12.11	12.11	12.11	12.11	Upgrade
Total Common Shares Outstanding	12.11	12.11	12.11	12.11	12.11	Upgrade
Working Capital	86.35	-106.79	-64.19	-17.28	17.41	Upgrade
Book Value Per Share	7.96	0.48	6.09	7.06	7.67	Upgrade
Tangible Book Value	96.35	5.84	73.77	85.46	92.85	Upgrade
Tangible Book Value Per Share	7.96	0.48	6.09	7.06	7.67	Upgrade
Order Backlog	-	-	2,144	1,203	601.88	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.